Evaluation of the causal associations between brain imaging-derived phenotypes and type 2 diabetes: a bidirectional Mendelian randomization study
Shan-Shan Dong,Ke Yu,Shi-Hao Tang,Jing Guo,Yan Guo,Tie-Lin Yang
DOI: https://doi.org/10.1101/2022.12.16.22283558
2022-01-01
Abstract:OBJECTIVE To investigate whether the association between brain imaging-derived phenotypes (IDPs) and Type 2 diabetes (T2D) related traits is causal.
DESIGN Two sample, bidirectional Mendelian randomization study.
SETTING Genome wide association study (GWAS) summary data taken from various cohorts comprised of the general population (mainly composed of Europeans).
PARTICIPANTS Summary data were used from previous GWAS. For IDPs, the data included up to 33,224 European individuals from the UK Biobank. For T2D-related traits, the number of participants ranged from 63,396 to 455,313.
MAIN OUTCOME MEASURES A total of 587 reliable IDPs and five T2D-related traits (T2D, fasting glucose, 2h-glucose post-challenge, glycated hemoglobin, and fasting insulin).
RESULTS We identified 3 IDPs with potential causal effects on T2D or fasting insulin. For example, we observed that the area of the right rostral middle frontal cortex was negatively associated with the T2D risk (OR = 0.74, 95% CI 0.65 to 0.85, P = 1.31 × 10−5). In addition, we identified potential causal effects of T2D-related traits on 6 IDPs. For example, T2D was negatively associated with the volumes of the right superior frontal gyrus (β = -0.05, 95% CI -0.08 to -0.03, P = 2.17 × 10−5) and the right paracentral lobule (β = -0.05, 95% CI -0.07 to -0.02, P = 1.74 × 10−4).
CONCLUSIONS Our results revealed strong genetic evidence for the bidirectional causal associations between brain neuroimaging phenotypes and T2D-related traits. This will contribute to better prediction and intervention for the risk of T2D.
### Competing Interest Statement
The authors have declared no competing interest.
### Funding Statement
This study is supported by the National Natural Science Foundation of China (32070588), the China Postdoctoral Science Foundation (2020M683454, 2021T140546), and the Fundamental Research Funds for the Central Universities. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at <https://open.win.ox.ac.uk/ukbiobank/big40/>; <https://diagram-consortium.org/downloads.html>; <https://magicinvestigators.org/downloads/>
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
All data produced in the present work are contained in the manuscript
* MR
: Mendelian randomization
T2D
: Type 2 diabetes
IDP
: Imaging-derived phenotype
GWAS
: genome-wide association studies
FG
: fasting glucose
2hGlu
: 2h-glucose post-challenge
HbA1c
: glycated hemoglobin
FI
: Fasting insulin
IV
: Instrument variant
LD
: Linkage disequilibrium
IVW
: Inverse variance weighted
MR-PRESSO
: MR pleiotropy residual sum and outlier